PULCHARIA THOMPSON: Open Payments
NPI 1568905446 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,340 in 106 payments from 15 companies in 2025. Trend: 2023 $1,615 · 2024 $2,166 · 2025 $2,340
Food & beverage: $2,330Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $514 |
| E.R. Squibb & Sons, L.L.C. | 13 | $434 |
| Otsuka America Pharmaceutical, Inc. | 11 | $361 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $250 |
| Alkermes, Inc. | 7 | $191 |
| Vanda Pharmaceuticals Inc. | 10 | $186 |
| Lundbeck LLC | 4 | $111 |
| Teva Pharmaceuticals USA, Inc. | 4 | $103 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
Products named: VRAYLAR, COBENFY, CAPLYTA, REXULTI, ARISTADA, FANAPT, ABILIFY MAINTENA, UZEDY.
Industry payments across TX — which companies pay providers there.
